elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43043023-44321339-DEF5-4D09-B1A1-3A2CADA4A64C
Q43043023-44321339-DEF5-4D09-B1A1-3A2CADA4A64C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43043023-44321339-DEF5-4D09-B1A1-3A2CADA4A64C
The other Achilles' heel of BCR-ABL1.
P2860
Q43043023-44321339-DEF5-4D09-B1A1-3A2CADA4A64C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43043023-44321339-DEF5-4D09-B1A1-3A2CADA4A64C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
489953e3b9c48d1410e5f5fa5aeff38dbedaefa8
P2860
Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase chronic myeloid leukemia patients with resistance, suboptimal response o